Article Text

PDF
Original article
Palliative care for patients with advanced fibrotic lung disease: a randomised controlled phase II and feasibility trial of a community case conference intervention
  1. Sabrina Bajwah1,2,
  2. Joy R Ross1,3,
  3. Athol U Wells3,4,
  4. Kabir Mohammed5,
  5. Christina Oyebode1,
  6. Surinder S Birring6,
  7. Amit S Patel6,
  8. Jonathan Koffman2,
  9. Irene J Higginson2,
  10. Julia Riley1,3
  1. 1Department of Palliative Medicine, Royal Marsden and Royal Brompton NHS Foundation Trusts, London, UK
  2. 2Department of Palliative Care, King's College London, Cicely Saunders Institute, Policy & Rehabilitation, London, UK
  3. 3National Heart and Lung Institute, Imperial College, London, UK
  4. 4Department of Respiratory Medicine, Royal Brompton NHS Foundation Trust, London, UK
  5. 5Department of Statistics, Royal Marsden NHS Foundation Trust, London, UK
  6. 6Division of Asthma, Allergy and Lung Biology, King's College London, London, UK
  1. Correspondence to Dr Sabrina Bajwah, Department of Palliative Care, Policy & Rehabilitation, Bessemer Rd, Cicely Saunders Institute, London SE5 9PJ, UK; sabrina.bajwah{at}kcl.ac.uk

Abstract

Background Those affected by advanced fibrotic interstitial lung diseases (ILDs) have considerable unmet symptom and psychological needs. Case conferencing has been proposed to address these issues, but requires evaluation.

Aim To obtain preliminary information on the impact of a case conference intervention delivered in the home (Hospital2Home) on palliative care concerns of patients and their carers, and to evaluate feasibility and acceptability.

Methods Hospital2Home was trialled at a specialist centre using a Phase II fast-track randomised controlled trial with qualitative interviews. The primary outcome for effect was mean change from baseline of Palliative Care Outcome Scale (POS) (a measure of symptoms and concerns) at 4 weeks. Secondary outcomes included symptom control, quality of life, consent and recruitment rates and percentage of patients in the fast-track group receiving case conferences within 14 days.

Results 53 patients were recruited (26 fast-track, 27 controls). Mean (SD) POS scores at 4 weeks were −5.7 (7.5) fast-track vs −0.4 (8.0) control, (mean change difference between the two arms was −5.3 (95% CI −9.8 to −0.7) independent t test p=0.02); effect size (95% CI) −0.7 (−1.2 to −0.1). The secondary outcomes of quality of life, anxiety and depression were superior in the fast-track arm, and none were worse. Qualitative findings corroborate these data. Recruitment was successful and 53/67 (79%) of eligible patients consented. 6/25 (24%) had case conferences within 14 days.

Conclusions Community case conferences improve palliative symptoms and quality of life after 4 weeks. Hospital2Home for the most part is both feasible and acceptable. It now requires further testing in multicentre trials.

Trial registration number NCT01450644

  • Idiopathic pulmonary fibrosis
  • Palliative Care

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.